latest news releases from the newsroom
CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013
UPDATE ON BERTILIMUMAB DEVELOPMENT AND EPICEPT MERGER PROCESS
HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS
WIRE (http://www.businesswire.com/))-- Regulatory News:
Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that Daniel Teper, Chief Executive Officer of Immune, will be presenting
at the BioEquity Europe 2013 conference at the Varumottagning Sheraton Hotel in
Alcobra Ltd. Prices Initial Public Offering of 3,125,000 Ordinary Shares
NEW YORK, May 21, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd., an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder, today announced the pricing of its initial public offering of 3,125,000 ordinary shares at an initial public offering price of $8.00 per share. The gross proceeds to Alcobra from the initial public offering are expected to be $25,000,000 before underwriting discounts and commissions and other offering expenses. Alcobra has granted the representative of the underwriters a 45-day option to purchase up to 458,125 additional ordinary shares from Alcobra to cover over-allotments, if any. The ordinary shares are scheduled to begin trading on The NASDAQ Capital Market on May 22, 2013 under the symbol "ADHD." The offering is expected to close on May 28, 2013, subject to customary closing conditions.
PGT Announces Increase in Size and Pricing of Secondary Offering
NORTH VENICE, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) ("PGT") announced today that JLL Partners Fund IV, L.P. (the "Selling Stockholder") has increased the size of the previously announced underwritten secondary offering (the "Offering") of 10,000,000 shares of its common stock by the Selling Stockholder, pursuant to PGT's shelf registration statement filed with the Securities and Exchange Commission (the "SEC"), to 11,000,000 shares and priced the Offering at $7.75 per share. The underwriters of the Offering have an option to purchase up to 1,650,000 additional shares from the Selling Stockholder. The Selling Stockholder will receive all of the proceeds from the Offering. No shares are being sold by PGT. The Offering is expected to close on May 28, 2013.
Rosetta Resources Inc.
Rosetta Resources Inc. to Present at Upcoming Investor Conferences
HOUSTON, May 21, 2013 (GLOBE NEWSWIRE) -- Rosetta Resources Inc. (Nasdaq:ROSE) ("Rosetta" or the "Company") today announced its participation in two upcoming investor conferences. Larry Jernigan, Vice President, Resource Management, will present on the Eagle Ford Panel at the SunTrust Robinson Humphrey 2013 "Play-by-Play" Oil & Gas Conference on Wednesday, May 29, 2013, at 2:05 p.m. Eastern Time. John Hagale, Executive Vice President and Chief Financial Officer, will present at the RBC 2013 Global Energy & Power Conference on Monday, June 3, 2013, at 3:35 p.m. Eastern Time. Both conferences will be held in New York City.
ShaMaran Petroleum Corp
ANNUAL GENERAL AND SPECIAL MEETING UPDATE
May 21, 2013 (SNM-TSXV & NASDAQ OMX: SNM). ShaMaran Petroleum Corp. ("ShaMaran"
or the "Company") (TSX VENTURE: SNM) (NASDAQ OMX: SNM) announces that, further
to the news release dated March 15, 2013, the Annual General and Special
Meeting of ShaMaran will be held at Suite 2000, 885 West Georgia Street,
Vancouver, British Columbia, V6C 3E8 on Tuesday, June 18, 2013, at 8:00 a.m.
(Vancouver time), for the following purposes:
1. to receive the consolidated audited financial statements of the